Notable Analyst Rating Changes 05/02: (LNKD) (ARUN) (ENDP) Upgraded; (PEG) (ECYT) (WSH) Downgraded
UBS boosts LinkedIn (NYSE: LNKD) from Neutral to Buy.
Oppenheimer upgrades Aruba Networks (Nasdaq: ARUN) from to Outperform with a price target of $24.
Morgan Stanley raises Endo Pharmaceuticals Holdings Inc (Nasdaq: ENDP) from Equalweight to Overweight.
Compass Point moves Beazer Homes (NYSE: BZH) from Neutral to Buy and lifts its price target by $1 to $25. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
RBC Capital lowers Public Service Enterprise Group Inc. (NYSE: PEG) from Outperform to Sector Perform and maintains its $39 price target.
Piper Jaffray downgrades Endocyte (Nasdaq: ECYT)